inExpose

SCIREQ recently attended this year’s Society For Research On Nicotine and Tobacco (SRNT 2021) Annual Meeting! This year’s theme was focused on social justice issues, health inequality, and [...]

Smoking has reached an epidemic proportion worldwide and its effect in terms of health-related issues is huge. While smoking prevention and cessation are key to bringing an end to this epidemic, [...]

Longitudinal studies offer a wealth of information, particularly for diseases progression or development studies. In addition, smaller sample sizes are possible to accumulate significant data, as [...]

SCIREQ will be attending the SOT Annual Meeting & ToxExpo in Baltimore from March 10-14, 2019. We invite you to come by booth #4109 to see a demonstration of our compact inhalation exposure [...]

Current use of inhalation exposure systems So far only a few studies use computerized inhalation exposure systems for nicotine delivery. Instead many preclinical researchers investigate the [...]

Studies addressing the potential risks associated with electronic cigarette (e-cig) usage are urgently needed, given their rising use and popularity, especially in youth.  Coordinated efforts are [...]

emka & SCIREQ offer a unique perspective into the preclinical study of heart and lung diseases, allowing for novel insights into cardiopulmonary diseases such as heart failure, arrhythmia, [...]

Many novel inhaled compounds and drugs require dry powder delivery and preclinical testing to assess efficacy and safety. The inExpose is an inhalation exposure system that provides a [...]

We are happy to announce the release of flexiWare 8.0!  This latest version is unified software for both the flexiVent and inExpose systems and flexiWare 8.0 includes features such as: [...]

Reproducibility is more than ever an inevitable topic in research.  Recently, the subject was addressed by Dr. Jason Bates1 specifically in relation to preclinical lung function measurements. As [...]